
Vaishali Sanchorawala
@vsanchorawala
Director, Amyloidosis Center @BU_Amyloidosis Hematologist and Oncologist @The_BMC
ID: 4049770233
http://www.bu.edu/amyloid 27-10-2015 00:34:58
2,2K Tweet
2,2K Followers
553 Following

Early molecular and transcriptional changes in AL cardiac amyloidosis BU Amyloidosis Center Abnormal global longitudinal strain and reduced serum inflammatory markers in cardiac AL amyloidosis patients without significant amyloid fibril deposition tandfonline.com/doi/full/10.10…

To my fellow physicians—on this National Doctors’ Day, I celebrate you, the long hours, the difficult conversations, the unwavering commitment to our patients. Wishing you strength, fulfillment, and a moment to reflect on the impact you make every day. BU Amyloidosis Center

Effective and safe treatment for this disease! #bispecificrocks BU Amyloidosis Center Teclistamab therapy for refractory type 1 cryoglobulinemia pubmed.ncbi.nlm.nih.gov/40109179/




Cardiac Amyloidosis in Older Adults With a Focus on Frailty: JACC: Advances Expert Consensus: JACC Journals 🥸 Ariela Orkaby MD MPH introduced me to @DrNikkiBart - and this turned out to be a great project 😱From American College of Cardiology geriatric cardiology leadership council: Summary 👇👇👇


Comprehensive, multidimensional geriatric assessment is essential in managing cardiac amyloidosis. Frailty, functional status, cognition, and social support must be integrated into care planning to optimize outcomes. BU Amyloidosis Center pubmed.ncbi.nlm.nih.gov/40373524/

